$INBX Inhibrx, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Inhibrx, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Inhibrx, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Inhibrx, Inc. for free.
IRS Number: 824257312
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: INBX
Company Address: 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA 92037
Phone number: (858) 759-1499
Former name: TENIUM THERAPEUTICS, INC.
Inhibrx, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 24 2021 | INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Of ... | Sell | S | 19.02 | 17,000 | 323,340 | 2,555,953 | 2.6 M to 2.6 M (-0.66 %) |
| Feb 18 2021 | INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Of ... | Sell | S | 25.90 | 17,000 | 440,300 | 2,572,953 | 2.6 M to 2.6 M (-0.66 %) |
| Feb 18 2021 | INBX | Inhibrx, Inc. | Wagner Klaus W. | Chief Medical Offic ... | Sell | S | 25.29 | 19,559 | 494,647 | 215,150 | 234.7 K to 215.2 K (-8.33 %) |
| Feb 18 2021 | INBX | Inhibrx, Inc. | Wagner Klaus W. | Chief Medical Offic ... | Sell | S | 24.32 | 156,474 | 3,805,448 | 234,709 | 391.2 K to 234.7 K (-40.00 %) |
| Jan 19 2021 | INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Of ... | Option Exercise | A | 33.63 | 40,000 | 1,345,200 | 40,000 | |
| Jan 19 2021 | INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Of ... | Gift | G | 0.00 | 80,000 | 0 | 80,000 | 0 to 80 K |
| Jan 19 2021 | INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Of ... | Gift | G | 0.00 | 80,000 | 0 | 80,000 | 0 to 80 K |
| Jan 19 2021 | INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Of ... | Gift | G | 0.00 | 160,000 | 0 | 2,589,953 | 2.7 M to 2.6 M (-5.82 %) |
| Jan 19 2021 | INBX | Inhibrx, Inc. | Wagner Klaus W. | Chief Medical Offic ... | Option Exercise | A | 33.63 | 120,000 | 4,035,600 | 120,000 | |
| Jan 19 2021 | INBX | Inhibrx, Inc. | Deck Kelly | Chief Financial Off ... | Option Exercise | A | 33.63 | 70,000 | 2,354,100 | 70,000 | |
| Jan 19 2021 | INBX | Inhibrx, Inc. | Lappe Mark | Chief Executive Off ... | Option Exercise | A | 33.63 | 145,000 | 4,876,350 | 145,000 | |
| Jan 19 2021 | INBX | Inhibrx, Inc. | Lappe Mark | Chief Executive Off ... | Gift | G | 0.00 | 500,000 | 0 | 500,000 | 0 to 500 K |
| Jan 19 2021 | INBX | Inhibrx, Inc. | Lappe Mark | Chief Executive Off ... | Gift | G | 0.00 | 500,000 | 0 | 2,590,252 | 3.1 M to 2.6 M (-16.18 %) |
| Aug 28 2020 | INBX | Inhibrx, Inc. | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 18.99 | 100,000 | 1,898,700 | 1,427,307 | 1.3 M to 1.4 M (+7.53 %) |
| Aug 28 2020 | INBX | Inhibrx, Inc. | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 18.84 | 80,219 | 1,511,166 | 1,327,307 | 1.2 M to 1.3 M (+6.43 %) |